o-krill.png
  1. Wassall, S.R.; Stillwell, W. Polyunsaturated fatty acid-cholesterol interactions: Domain formation in membranes. Biochimi. Biophys. Acta 2009, 1788, 24–32.
  2. Riediger, N.D.; Othman, R.A.; Suh, M.; Moghadasian, M.H. A systemic review of the roles of n-3 fatty acids in health and disease. J. Am. Dietet. Assoc. 2009, 109, 668–679.
  3. Bang, H.O.; Dyerberg, J.; Nielsen, A.B. Plasma lipid and lipoprotein pattern in Greenlandic West-coast Eskimos. Lancet 1971, 1, 1143–1145.
  4. Dyerberg, J.; Bang, H.O.; Hjorne, N. Fatty acid composition of the plasma lipids in Greenland Eskimos. Am. J. Clin. Nutr. 1975, 28, 958–966.
  5. Cottin, S.C.; Sanders, T.A.; Hall, W.L. The differential effects of EPA and DHA on cardiovascular risk factors. Proc. Nutr. Soc. 2011, 70, 215–231.
  6. Banni, S.; Di Marzo, V. Effect of dietary fat on endocannabinoids and related mediators: Consequences on energy homeostasis, inflammation and mood. Mol.Nutr.Food Res. 2010, 54, 82–92.
  7. Lu, F.S.; Nielsen, N.S.; Timm-Heinrich, M.; Jacobsen, C. Oxidative stability of marine phospholipids in the liposomal form and their applications. Lipids2011, 46, 3–23.
  8. Higuchi, T.; Shirai, N.; Suzuki, H. Effects of dietary herring roe lipids on plasma lipid, glucose, insulin, and adiponectin concentrations in mice. J. Agric. Food Chem. 2006, 54, 3750–3755.
  9. Shirai, N.; Higuchi, T.; Suzuki, H. Effect of lipids extracted from a salted herring roe food product on maze-behavior in mice. J. Nutr. Sci. Vitaminol. (Tokyo) 2006, 52, 451–456.
  10. Hayashi, H.; Tanaka, Y.; Hibino, H.; Umeda, Y.; Kawamitsu, H.; Fujimoto, H.; Amakawa, T. Beneficial effect of salmon roe phosphatidylcholine in chronic liver disease. Curr. Med. Res. Opin. 1999, 15, 177–184.
  11. Shirai, N.; Higuchi, T.; Suzuki, H. Analysis of lipid classes and the fatty acid composition of the salted fish roe food products, Ikura, Tarako, Tobiko and Kazunoko. Food Chem. 2006, 94, 61–67.
  12. Lieber, C.S.; Robins, S.J.; Li, J.; DeCarli, L.M.; Mak, K.M.; Fasulo, J.M.; Leo, M.A. Phosphatidylcholine protects against fibrosis and cirrhosis in the baboon. Gastroenterology 1994, 106, 152–159.
  13. Loy, R.; Heyer, D.; Williams, C.L.; Meck, W.H. Choline-induced spatial memory facilitation correlates with altered distribution and morphology of septal neurons. Adv. Exp. Med. Biol. 1991, 295, 373–382.
  14. Phleger, C.F.; Nelson, M.M.; Mooney, B.D.; Nichols, P.D. Interannual and between species comparison of the lipids, fatty acids and sterols of Antarctic krill from the US AMLR Elephant Island survey area. Comp. Biochem. Physiol. B Biochem. Mol. Biol. 2002, 131, 733–747.
  15. Tou, J.C.; Jaczynski, J.; Chen, Y.C. Krill for human consumption: Nutritional value and potential health benefits. Nutr.Rev. 2007, 65, 63–77.
  16. Le Grandois, J.; Marchioni, E.; Zhao, M.; Giuffrida, F.; Ennahar, S.; Bindler, F. Investigation of natural phosphatidylcholine sources: Separation and identification by liquid chromatography-electrospray ionization-tandem mass spectrometry (LC-ESI-MS2) of molecular species. J. Agric. Food Chem. 2009, 57, 6014–6020.
  17. Winther, B.; Hoem, N.; Berge, K.; Reubsaet, L. Elucidation of phosphatidylcholine composition in krill oil extracted from Euphausia superba. Lipids 2011, 46, 25–36.
  18. Hjaltason, B.; Haraldsson, G.G. Fish Oils and Lipids from Marine Sources. In Modifying Lipids for Use in Food; Gunstone, F.D., Ed.; Woodhead Publishing: Cambridge, UK, 2006; pp. 57–79.
  19. Xu, R.; Hung, J.B.; German, J.B. Effects of dietary lipids on the fatty acid composition of triglycerides and phospholipids in tissues of white sturgeon. Aquacult. Nutr. 1996, 2, 101–109.
  20. Polvi, S.M.; Ackman, R.G. Atlantic salmon (Salmo salar) muscle lipids and their response to alternative dietary fatty acid sources. J. Agric. Food Chem. 1992, 40, 1001–1007.
  21. Strobel, C.; Jahreis, G.; Kuhnt, K. Survey of n-3 and n-6 polyunsaturated fatty acids in fish and fish products. LipidsHealthDis.2012, 11, 144.
  22. Ulven, S.M.; Kirkhus, B.; Lamglait, A.; Basu, S.; Elind, E.; Haider, T.; Berge, K.; Vik, H.; Pedersen, J.I. Metabolic effects of krill oil are essentially similar to those of fish oil but at lower dose of EPA and DHA, in healthy volunteers. Lipids2011, 46, 37–46.
  23. Carlier, H.; Bernard, A.; Caselli, C. Digestion and absorption of polyunsaturated fatty acids.
  24. Iqbal, J.; Hussain, M.M. Intestinal lipid absorption. Am. J. Physiol. Endocrinol. Metab. 2009,
  25. Friedman, H.I.; Nylund, B. Intestinal fat digestion, absorption, and transport. A review. Am. J. Clin. Nutr. 1980, 33, 1108–1139.
  26. Krimbou, L.; Hassan, H.H.; Blain, S.; Rashid, S.; Denis, M.; Marcil, M.; Genest, J. Biogenesis and speciation of nascent apoA-I-containing particles in various cell lines. J.Lipid Res. 2005, 46, 1668–1677.
  27. Magun, A.M.; Mish, B.; Glickman, R.M. Intracellular apoA-I and apoB distribution in rat intestine is altered by lipid feeding. J. Lipid Res. 1988, 29, 1107–1116.
  28. Wang, H.; Du, J.; Lu, S.; Yao, Y.; Hunter, F.; Black, D.D. Regulation of intestinal apolipoprotein A-I synthesis by dietary phosphatidylcholine in newborn swine. Lipids 2001, 36, 683–687.
  29. Brunham, L.R.; Kruit, J.K.; Iqbal, J.; Fievet, C.; Timmins, J.M.; Pape, T.D.; Coburn, B.A.; Bissada, N.; Staels, B.; Groen, A.K.; et al. Intestinal ABCA1 directly contributes to HDL biogenesis in vivo. J. Clin. Invest. 2006, 116, 1052–1062.
  30. Forester, G.P.; Tall, A.R.; Bisgaier, C.L.; Glickman, R.M. Rat intestine secretes spherical high density lipoproteins. J. Biol. Chem. 1983, 258, 5938–5943.
  31. Green, P.H.; Tall, A.R.; Glickman, R.M. Rat intestine secretes discoid high density lipoprotein.
  32. Preiss-Landl, K.; Zimmermann, R.; Hammerle, G.; Zechner, R. Lipoprotein lipase: The regulation of tissue specific expression and its role in lipid and energy metabolism. Curr. Opin. Lipidol. 2002, 13, 471–481.
  33. Yamashita, S.; Hirano, K.; Sakai, N.; Matsuzawa, Y. Molecular biology and pathophysiological aspects of plasma cholesteryl ester transfer protein. Biochim. Biophys. Acta 2000, 1529, 257–275.
  34. Amate, L.; Gil, A.; Ramirez, M. Dietary long-chain polyunsaturated fatty acids from different sources affect fat and fatty acid excretions in rats. J. Nutr. 2001, 131, 3216–3221.
  35. Sala-Vila, A.; Campoy, C.; Castellote, A.I.; Garrido, F.J.; Rivero, M.; Rodriguez-Palmero, M.; Lopez-Sabater, M.C. Influence of dietary source of docosahexaenoic and arachidonic acids on their incorporation into membrane phospholipids of red blood cells in term infants. Prostaglandins Leukotrienes Essent. Fatty Acids 2006, 74, 143–148.
  36. Sala-Vila, A.; Castellote, A.I.; Campoy, C.; Rivero, M.; Rodriguez-Palmero, M.; Lopez-Sabater, M.C. The source of long-chain PUFA in formula supplements does not affect the fatty acid composition of plasma lipids in full-term infants. J. Nutr. 2004, 134, 868–873.
  37. Valenzuela, A.; Nieto, S.; Sanhueza, J.; Nunez, M.J.; Ferrer, C. Tissue accretion and milk content of docosahexaenoic acid in female rats after supplementation with different docosahexaenoic acid sources. Ann. Nutr. Metab. 2005, 49, 325–332.
  38. Valenzuela, A.; Valenzuela, V.; Sanhueza, J.; Nieto, S. Effect of supplementation with docosahexaenoic acid ethyl ester and sn-2 docosahexaenyl monoacylglyceride on plasma and erythrocyte fatty acids in rats. Ann. Nutr. Metab. 2005, 49, 49–53.
  39. Amate, L.; Gil, A.; Ramirez, M. Feeding infant piglets formula with long-chain polyunsaturated fatty acids as triacylglycerols or phospholipids influences the distribution of these fatty acids in plasma lipoprotein fractions. J. Nutr. 2001, 131, 1250–1255.
  40. Lagarde, M.; Bernoud, N.; Brossard, N.; Lemaitre-Delaunay, D.; Thies, F.; Croset, M.; Lecerf, J. Lysophosphatidylcholine as a preferred carrier form of docosahexaenoic acid to the brain. J. Mol. Neurosci. 2001, 16, 201–204; discussion 215–221.
  41. Picq, M.; Chen, P.; Perez, M.; Michaud, M.; Vericel, E.; Guichardant, M.; Lagarde, M. DHA metabolism: Targeting the brain and lipoxygenation. Mol. Neurobiol. 2010, 42, 48–51.
  42. Graf, B.A.; Duchateau, G.S.; Patterson, A.B.; Mitchell, E.S.; van Bruggen, P.; Koek, J.H.; Melville, S.; Verkade, H.J. Age dependent incorporation of 14C-DHA into rat brain and body tissues after dosing various 14C-DHA-esters. Prostaglandins Leukotrienes Essent. Fatty Acids 2010, 83, 89–96.
  43. Wijendran, V.; Huang, M.C.; Diau, G.Y.; Boehm, G.; Nathanielsz, P.W.; Brenna, J.T. Efficacy of dietary arachidonic acid provided as triglyceride or phospholipid as substrates for brain arachidonic acid accretion in baboon neonates. Pediatr. Res. 2002, 51, 265–272.
  44. Batetta, B.; Griinari, M.; Carta, G.; Murru, E.; Ligresti,  A.;  Cordeddu,  L.;  Giordano,  E.; Sanna, F.; Bisogno, T.; Uda, S.; et al. Endocannabinoids may mediate the ability of (n-3) fatty acids to reduce ectopic fat and inflammatory mediators in obese Zucker rats. J. Nutr. 2009, 139, 1495–501.
  45. Di Marzo, V.; Griinari, M.; Carta, G.; Murru, E.; Ligresti, A.; Cordeddu, L.; Giordano, E.; Bisogno, T.; Collu, M.; Batetta, B.; et al. Dietary krill oil increases docosahexaenoic acid and reduces 2-arachidonoylglycerol but not N-acylethanolamine levels in the brain of obese Zucker rats. Int. Dairy J. 2010, 20, 231–235.
  46. Gamoh, S. Krill-derived phospholipids rich in n-3 fatty acid improve spatial memory in adult rats. J. Agric. Sci. 2011, 3, 3–12.
  47. Thies, F.; Delachambre, M.C.; Bentejac, M.; Lagarde, M.; Lecerf, J. Unsaturated fatty acids esterified in 2-acyl-l-lysophosphatidylcholine bound to albumin are more efficiently taken up by the young rat brain than the unesterified form. J. Neurochem. 1992, 59, 1110–1116.
  48. Thies, F.; Pillon, C.; Moliere, P.; Lagarde, M.; Lecerf, J. Preferential incorporation of sn-2 lysoPC DHA over unesterified DHA in the young rat brain. Am.J.Physiol.1994, 267, R1273–R1279.
  49. Cansell, M. Marine phospholipids as dietary carriers of long-chain polyunsaturated fatty acids.
  50. Cansell, M.; Moussaoui, N.; Petit, A.P.; Denizot, A.; Combe, N. Feeding rats with liposomes or fish oil differently affects their lipid metabolism. Eur. J. Lipid Sci. Technol. 2006, 108, 459–467.
  51. Cansell, M.; Nacka, F.; Combe, N. Marine lipid-based liposomes increase in vivo FA bioavailability. Lipids 2003, 38, 551–559.
  52. Cansell, M.S.; Battin, A.; Degrace, P.; Gresti, J.; Clouet, P.; Combe, N. Early dissimilar fates of liver eicosapentaenoic acid in rats fed liposomes or fish oil and gene expression related to lipid metabolism. Lipids 2009, 44, 237–247.
  53. Cole, G.M.; Ma, Q.L.; Frautschy, S.A. Dietary fatty acids and the aging brain. Nutr. Rev. 2010,
  54. Schaefer, E.J.; Bongard, V.; Beiser, A.S.; Lamon-Fava, S.; Robins, S.J.; Au, R.; Tucker, K.L.; Kyle, D.J.; Wilson, P.W.; Wolf, P.A. Plasma phosphatidylcholine docosahexaenoic acid content and risk of dementia and Alzheimer disease: The Framingham Heart Study. Arch. Neurol. 2006, 63, 1545–1550.
  55. Lemaitre-Delaunay, D.; Pachiaudi, C.; Laville, M.; Pousin, J.; Armstrong, M.; Lagarde, M. Blood compartmental metabolism of docosahexaenoic acid (DHA) in humans after ingestion of a single dose of [(13)C]DHA in phosphatidylcholine. J. Lipid Res. 1999, 40, 1867–1874.
  56. Bunea, R.; El Farrah, K.; Deutsch, L. Evaluation of the effects of neptune krill oil on the clinical course of hyperlipidemia. Altern. Med. Rev. 2004, 9, 420–428.
  57. Banni, S.; Carta, G.; Murru, E.; Cordeddu, L.; Giordano, E.; Sirigu, A.R.; Berge, K.; Vik, H.; Maki, K.C.; Di Marzo, V.; et al. Krill oil significantly decreases 2-arachidonoylglycerol plasma levels in obese subjects. Nutr. Metab. (Lond) 2011, 8, 7.
  58. Deutsch, L. Evaluation of the effect of neptune krill oil on chronic inflammation and arthritic symptoms. J. Am. Coll. Nutr. 2007, 26, 39–48.
  59. Skarpańska-Stejnborn, A.; Pilaczyńska-Szcześniak, L.; Basta, P.; Foriasz, J.; Arlet, J. Effects of supplementation with neptune krill oil (Euphasia Superba) on selected redox parameters and pro-Inflammatory markers in athletes during exhaustive exercise. J.Hum.Kinet.2010, 25, 49–57.
  60. Sampalis, F.; Bunea, R.; Pelland, M.F.; Kowalski, O.; Duguet, N.; Dupuis, S. Evaluation of the effects of neptune krill oil on the management of premenstrual syndrome and dysmenorrhea. Altern. Med. Rev. 2003, 8, 171–179.
  61. Richter, Y.; Herzog, Y.; Cohen, T.; Steinhart, Y. The effect of phosphatidylserine-containing omega-3 fatty acids on memory abilities in subjects with subjective memory complaints: A pilot study. Clin. Interv. Aging 2010, 5, 313–316.
  62. Vaisman, N.; Kaysar, N.; Zaruk-Adasha, Y.; Pelled, D.; Brichon, G.; Zwingelstein, G.; Bodennec, J. Correlation between changes in blood fatty acid composition and visual sustained attention performance in children with inattention: Effect of dietary n-3 fatty acids containing phospholipids. Am. J. Clin. Nutr. 2008, 87, 1170–1180.
  63. Maki, K.C.; Reeves, M.S.; Farmer, M.; Griinari, M.; Berge,  K.;  Vik,  H.;  Hubacher,  R.; Rains, T.M. Krill oil supplementation increases plasma concentrations of eicosapentaenoic and docosahexaenoic acids in overweight and obese men and women. Nutr.Res. 2009, 29, 609–615.
  64. Schuchardt, J.P.; Schneider, I.; Meyer, H.; Neubronner, J.; von Schacky, C.; Hahn, A. Incorporation of EPA and DHA into plasma phospholipids in response to different omega-3 fatty acid formulations—A comparative bioavailability study of fish oil vs. krill oil. LipidsHealthDis.2011, 10, 145.
  65. Fosshaug, L.E.; Berge, R.K.; Beitnes, J.O.; Berge, K.; Vik, H.; Aukrust, P.; Gullestad, L.; Vinge, L.E.; Oie, E. Krill oil attenuates left ventricular dilatation after myocardial infarction in rats. LipidsHealthDis.2011, 10, 245.
  66. Higuchi, T.; Shirai, N.; Suzuki, H. Effects of herring roe on plasma lipid, glucose, insulin and adiponectin levels, and hepatic lipid contents in mice. J. Nutr. Sci. Vitaminol. (Tokyo) 2008, 54, 230–236.
  67. Rossmeisl, M.; Jilkova, Z.M.; Kuda, O.; Jelenik,  T.;  Medrikova,  D.;  Stankova,  B.; Kristinsson, B.; Haraldsson, G.G.; Svensen, H.; Stoknes, I.; et al. Metabolic effects of n-3 PUFA as phospholipids are superior to triglycerides  in mice fed a high-fat  diet: Possible role of endocannabinoids. PLoS One 2012, 7, e38834.
  68. Ferramosca, A.; Conte, A.; Burri, L.; Berge, K.; De Nuccio, F.; Giudetti, A.M.; Zara, V. A krill oil supplemented diet suppresses hepatic steatosis in high-fat fed rats. PLoSOne2012, 7, e38797.
  69. Piscitelli, F.; Carta, G.; Bisogno, T.; Murru, E.; Cordeddu, L.; Berge, K.; Tandy, S.; Cohn, J.S.; Griinari, M.; Banni, S.; et al. Effect of dietary krill oil supplementation on the endocannabinoidome of metabolically relevant tissues from high fat-fed mice. Nutr.Metab. 2011, 8, 1–16.
  70. Tandy, S.; Chung, R.W.S.; Wat, E.; Kamili, A.; Berge, K.; Griinari, M.; Cohn, J.S. Dietary krill oil supplementation reduces hepatic steatosis, glycemia and hypercholesterolemia in high-fat fed mice. J. Agric. Food Chem. 2009, 57, 9339–9345.
  71. Moriya, H.; Hosokawa, M.; Miyashita, K. Combination effect of herring roe lipids and proteins on plasma lipids and abdominal fat weight of mouse. J. Food Sci. 2007, 72, C231–C234.
  72. Bjorndal, B.; Burri, L.; Wergedahl, H.; Svardal, A.; Bohov, P.; Berge, R.K. Dietary supplementation of herring roe and milt enhances hepatic fatty acid catabolism in female mice transgenic for hTNFalpha. Eur. J. Nutr. 2012, 51, 741–753.
  73. Vigerust, N.F.; Bjorndal, B.; Bohov, P.; Brattelid, T.; Svardal, A.; Berge, R.K. Krill oil versus fish oil in modulation of inflammation and lipid metabolism in mice transgenic for TNF-alpha. Eur. J. Nutr. 2012, doi:10.1007/s00394-012-0441-2.
  74. Grimstad, T.; Bjorndal, B.; Cacabelos, D.; Aasprong, O.G.; Janssen, E.A.; Omdal, R.; Svardal, A.; Hausken, T.; Bohov, P.; Portero-Otin, M.; et al. Dietary supplementation of krill oil attenuates inflammation and oxidative stress in experimental ulcerative colitis in rats. Scand.J.Gastroenterol. 2012, 47, 49–58.
  75. Ierna, M.; Kerr, A.; Scales, H.; Berge, K.; Griinari, M. Supplementation of diet with krill oil protects against experimental rheumatoid arthritis. BMC Musculoskeletal Disord. 2010, 11, 136.
  76. Lee, B.; Sur, B.J.; Han, J.J.; Shim, I.; Her, S.; Lee, H.J.; Hahm, D.H. Krill phosphatidylserine improves learning and memory in Morris water maze in aged rats. Prog. Neuropsychopharmacol. Biol. Psychiatry 2010, 34, 1085–1093.
  77. Lukas, R.; Gigliotti, J.C.; Smith, B.J.; Altman, S.; Tou, J.C. Consumtion of different sources of omega-3 polyunsaturated fatty acids by growing female rats affects long bone mass and microarchitecture. Bone 2011, 49, 455–462.
  78. Ferramosca, A.; Conte, L.; Zara, V. A krill oil supplemented diet reduces the activities of the mitochondrial tricarboxylate carrier and of the cytosolic lipogenic enzymes in rats. J. Anim. Physiol. Anim. Nutr. 2011, 1–12.
  79. Burri, L.; Berge, K.; Wibrand, K.; Berge, R.K.; Barger, J.L. Differential effects of krill oil and fish oil on the hepatic transcriptome in mice. Front. Genet. 2011, 2, 1–8.
  80. Hung, M.C.; Shibasaki, K.; Yoshida, R.; Sato, M.; Imaizumi, K. Learning behaviour and cerebral protein kinase C, antioxidant status, lipid composition in senescence-accelerated mouse: Influence of a phosphatidylcholine-vitamin B12 diet. Br. J. Nutr. 2001, 86, 163–171.
  81. Chung, S.Y.; Moriyama, T.; Uezu, E.; Uezu, K.; Hirata, R.; Yohena, N.; Masuda,  Y.; Kokubu, T.; Yamamoto, S. Administration of phosphatidylcholine increases brain acetylcholine concentration and improves memory in mice with dementia. J. Nutr. 1995, 125, 1484–1489.
  82. Schneider, H.; Braun, A.; Fullekrug, J.; Stremmel, W.; Ehehalt, R. Lipid based therapy for ulcerative colitis-modulation of intestinal mucus membrane phospholipids as a tool to influence inflammation. Int. J. Mol. Sci. 2010, 11, 4149–4164.
  83. Buang, Y.; Wang, Y.M.; Cha, J.Y.; Nagao, K.; Yanagita, T. Dietary phosphatidylcholine alleviates fatty liver induced by orotic acid. Nutrition2005, 21, 867–873.
  84. O’Brien, B.C.; Andrews, V.G. Influence of dietary egg and soybean phospholipids and triacylglycerols on human serum lipoproteins. Lipids1993, 28, 7–12.
  85. Jager, R.; Purpura, M.; Geiss, K.R.; Weiss, M.; Baumeister, J.; Amatulli, F.; Schroder, L.; Herwegen, H. The effect of phosphatidylserine on golf performance. J. Int. Soc. Sports Nutr. 2007, 4, 23.
  86. Jager, R.; Purpura, M.; Kingsley, M. Phospholipids and sports performance. J. Int. Soc. Sports Nutr. 2007, 4, 5.
  87. An, B.K.; Nishiyama, H.; Tanaka, K.; Ohtani, S.; Iwata, T.; Tsutsumi, K.; Kasai, M. Dietary safflower phospholipid reduces liver lipids in laying hens. Poult. Sci. 1997, 76, 689–695.
  88. Imaizumi, K.; Mawatari, K.; Murata, M.; Ikeda, I.; Sugano, M. The contrasting effect of dietary phosphatidylethanolamine and phosphatidylcholine on serum lipoproteins and liver lipids in rats. J. Nutr. 1983, 113, 2403–2411.
  89. Iwata, T.; Hoshi, S.; Takehisa, F.; Tsutsumi, K.; Furukawa, Y.; Kimura, S. The effect of dietary safflower phospholipid and soybean phospholipid on plasma and liver lipids in rats fed a hypercholesterolemic diet. J. Nutr. Sci. Vitaminol. (Tokyo) 1992, 38, 471–479.
  90. Kabir, Y.; Ide, T. Effect of dietary soybean phospholipid and fats differing in the degree of unsaturation on fatty acid synthesis and oxidation in rat liver. J. Nutr. Sci. Vitaminol. (Tokyo) 1995, 41, 635–645.
  91. LeBlanc, M.J.; Brunet, S.; Bouchard, G.; Lamireau, T.; Yousef, I.M.; Gavino, V.; Levy, E.; Tuchweber, B. Effects of dietary soybean lecithin on plasma lipid transport and hepatic cholesterol metabolism in rats. J.Nutr.Biochem. 2003, 14, 40–48.
  92. Polichetti, E.; Diaconescu, N.; De La Porte, P.L.; Malli, L.; Portugal, H.; Pauli, A.M.; Lafont, H.; Tuchweber, B.; Yousef, I.; Chanussot, F. Cholesterol-lowering effect of soyabean lecithin in normolipidaemic rats by stimulation of biliary lipid secretion. Br. J. Nutr. 1996, 75, 471–478.
  93. Polichetti, E.; Janisson, A.; de la Porte, P.L.; Portugal, H.; Leonardi, J.; Luna, A.; La Droitte, P.; Chanussot, F. Dietary polyenylphosphatidylcholine decreases cholesterolemia in hypercholesterolemic rabbits: Role of the hepato-biliary axis. Life Sci. 2000, 67, 2563–2576.
  94. Shirouchi, B.; Nagao, K.; Inoue, N.; Ohkubo, T.; Hibino, H.; Yanagita, T. Effect of dietary omega-3 phosphatidylcholine on obesity-related disorders in obese Otsuka Long-Evans Tokushima fatty rats. J. Agric. Food Chem. 2007, 55, 7170–7176.
  95. Lieber, C.S. New concepts of the pathogenesis of alcoholic liver disease lead to novel treatments.
  96. Lieber, C.S. Alcoholic fatty liver: Its pathogenesis and mechanism of progression to inflammation and fibrosis. Alcohol 2004, 34, 9–19.
  97. Turecky, L.; Kupcova, V.; Szantova, M.; Uhlikova, E. Plasma lipid parameters in patients with alcoholic fatty liver after treatment with essential phospholipids. Bratisl. Lek. Listy 2003, 104, 227–231.
  98. Puri, P.; Baillie, R.A.; Wiest, M.M.; Mirshahi, F.; Choudhury, J.; Cheung, O.; Sargeant, C.; Contos, M.J.; Sanyal, A.J. A lipidomic analysis of nonalcoholic fatty liver disease. Hepatology2007, 46, 1081–1090.
  99. Cohn, J.S.; Wat, E.; Kamili, A.; Tandy, S. Dietary phospholipids, hepatic lipid metabolism and cardiovascular disease. Curr.Opin.Lipidol.2008, 19, 257–262.
  100. Dasgupta, S.; Bhattacharyya, D.K. Dietary effect of eicosapentaenoic acid (EPA) containing soyphospholipid. J. Oleo Sci. 2007, 56, 563–568.
  101. Zeisel, S.H.; Mar, M.H.; Howe, J.C.; Holden, J.M. Concentrations of choline-containing compounds and betaine in common foods. J. Nutr. 2003, 133, 1302–1307.
  102. Deiana, S.; Platt, B.; Riedel, G. The cholinergic system and spatial learning. Behav.BrainRes.
  103. McDaniel,  M.A.;  Maier,  S.F.;  Einstein,  G.O.  “Brain-specific”  nutrients:  A  memory  cure?
  104. Da Costa, K.A.; Cochary, E.F.; Blusztajn, J.K.; Garner, S.C.; Zeisel, S.H. Accumulation of 1,2-sn-diradylglycerol with increased membrane-associated protein kinase C may be the mechanism for spontaneous hepatocarcinogenesis in choline-deficient rats. J. Biol. Chem. 1993, 268, 2100–2105.
  105. Zeisel, S.H.; Da Costa, K.A.; Franklin, P.D.; Alexander, E.A.; Lamont, J.T.; Sheard, N.F.; Beiser, A. Choline, an essential nutrient for humans. FASEB J. 1991, 5, 2093–2098.
  106. Zeisel, S.H. Choline: Needed for normal development of memory. J. Am. Coll. Nutr. 2000, 19, 528S–531S.
  107. Meck, W.H.; Williams, C.L. Perinatal choline supplementation increases the threshold for chunking in spatial memory. Neuroreport 1997, 8, 3053–3059.
  108. Meck, W.H.; Williams, C.L. Simultaneous temporal processing is sensitive to prenatal choline availability in mature and aged rats. Neuroreport1997, 8, 3045–3051.
  109. Meck, W.H.; Williams, C.L. Characterization of the facilitative effects of perinatal choline supplementation on timing and temporal memory. Neuroreport 1997, 8, 2831–2835.
  110. Tees, R.C. The influences of rearing environment and neonatal choline dietary supplementation on spatial learning and memory in adult rats. Behav. Brain Res. 1999, 105, 173–188.
  111. Williams, C.L.; Meck, W.H.; Heyer, D.D.; Loy, R. Hypertrophy of basal forebrain neurons and enhanced visuospatial memory in perinatally choline-supplemented rats. Brain Res. 1998, 794, 225–238.
  112. Albright, C.D.; Tsai, A.Y.; Friedrich, C.B.; Mar, M.H.; Zeisel, S.H. Choline availability alters embryonic development of the hippocampus and septum in the rat. Brain Res. Dev. Brain Res. 1999, 113, 13–20.
  113. Albright, C.D.; Zeisel, S.H. Choline deficiency causes increased localization of transforming growth factor-beta1 signaling proteins and apoptosis in the rat liver. Pathobiology 1997, 65, 264–270.
  114. Holmes-McNary, M.Q.; Loy, R.; Mar, M.H.; Albright, C.D.; Zeisel, S.H. Apoptosis is induced by choline deficiency in fetal brain and in PC12 cells. Brain Res. Dev. Brain Res. 1997, 101, 9–16.
  115. Xu, X.; Gammon, M.D.; Zeisel, S.H.; Bradshaw, P.T.; Wetmur, J.G.; Teitelbaum, S.L.; Neugut, A.I.; Santella, R.M.; Chen, J. High intakes of choline and betaine reduce breast cancer mortality in a population-based study. FASEB J. 2009, 23, 4022–4028.
  116. Xu, X.; Gammon, M.D.; Zeisel,  S.H.;  Lee,  Y.L.;  Wetmur,  J.G.;  Teitelbaum,  S.L.; Bradshaw, P.T.; Neugut, A.I.; Santella, R.M.; Chen, J. Choline metabolism and risk of breast cancer in a population-based study. FASEBJ.2008, 22, 2045–2052.
  117. Lee, J.E.; Giovannucci, E.; Fuchs, C.S.; Willett, W.C.; Zeisel, S.H.; Cho, E. Choline and betaine intake and the risk of colorectal cancer in men. Cancer Epidemiol. Biomarkers Prev. 2010, 19, 884–887.
  118. Jump, D.B.; Botolin, D.; Wang, Y.; Xu, J.; Christian, B.; Demeure, O. Fatty acid regulation of hepatic gene transcription. J. Nutr. 2005, 135, 2503–2506.
  119. Arita, M.; Yoshida, M.; Hong, S.; Tjonahen, E.; Glickman, J.N.; Petasis, N.A.; Blumberg, R.S.; Serhan, C.N. Resolvin E1, an endogenous lipid mediator derived from omega-3 eicosapentaenoic acid, protects against 2,4,6-trinitrobenzene sulfonic acid-induced colitis. Proc. Natl. Acad. Sci. USA 2005, 102, 7671–7676.
  120. Davidson, M.H. Mechanisms for the hypotriglyceridemic effect of marine omega-3 fatty acids.
  121. Hoffman, D.R.; Boettcher, J.A.; Diersen-Schade, D.A. Toward optimizing vision and cognition in term infants by dietary docosahexaenoic and arachidonic acid supplementation: A review of randomized controlled trials. Prostaglandins Leukotrienes Essent. Fatty Acids 2009, 81, 151–158.
  122. Iso, H.; Kobayashi, M.; Ishihara, J.; Sasaki, S.; Okada, K.; Kita, Y.; Kokubo, Y.; Tsugane, S. Intake of fish and n3 fatty acids and risk of coronary heart disease among Japanese: The Japan Public Health Center-Based (JPHC) study cohort I. Circulation 2006, 113, 195–202.
  123. Serini, S.; Piccioni, E.; Calviello, G. Dietary n-3 PUFA vascular targeting and the prevention of tumor growth and age-related macular degeneration. Curr. Med. Chem. 2009, 16, 4511–4526.
  124. Von Schacky, C.;  Angerer, P.; Kothny, W.;  Theisen,  K.;  Mudra, H.  The  effect  of  dietary omega-3 fatty acids on coronary atherosclerosis. A randomized, double-blind, placebo-controlled trial. Ann. Intern. Med. 1999, 130, 554–562.
  125. Weitz, D.; Weintraub, H.; Fisher, E.; Schwartzbard, A.Z. Fish oil for the treatment of cardiovascular disease. Cardiol.Rev. 2010, 18, 258–263.
  126. Wu, M.; Harvey, K.A.; Ruzmetov, N.; Welch, Z.R.; Sech, L.; Jackson,  K.;  Stillwell,  W.; Zaloga, G.P.; Siddiqui, R.A. Omega-3 polyunsaturated fatty acids attenuate breast cancer growth through activation of a neutral sphingomyelinase-mediated pathway. Int.J. Cancer 2005, 117, 340–348.
  127. Yurko-Mauro, K. Cognitive and cardiovascular benefits of docosahexaenoic acid in aging and cognitive decline. Curr. Alzheimer Res. 2010, 7, 190–196.
  128. Horrobin, D.F. Interactions between n-3 and n-6 essential fatty acids (EFAs) in the regulation of cardiovascular disorders and inflammation. Prostaglandins Leukotrienes Essent. Fatty Acids 1991, 44, 127–131.
  129. Morris, M.C.; Evans, D.A.; Bienias, J.L.; Tangney, C.C.; Bennett, D.A.; Wilson, R.S.; Aggarwal, N.; Schneider, J. Consumption of fish and n-3 fatty acids and risk of incident Alzheimer disease. Arch.Neurol.2003, 60, 940–946.
  130. Richardson, A.J.; Puri, B.K. A randomized double-blind, placebo-controlled study of the effects of supplementation with highly unsaturated fatty acids on ADHD-related symptoms in children with specific learning difficulties. Prog. Neuropsychopharmacol. Biol. Psychiatry 2002, 26, 233–239.
  131. Chowdhury, R.; Stevens, S.; Gorman, D.; Pan, A.; Warnakula, S.; Chowdhury, S.; Ward, H.; Johnson, L.; Crowe, F.; Hu, F.B.; et al. Association between fish consumption, long chain omega 3 fatty acids, and risk of cerebrovascular disease: Systematic review and meta-analysis. BMJ2012, 345, e6698.
  132. Hooper, L.; Thompson, R.L.; Harrison, R.A.; Summerbell, C.D.; Ness, A.R.; Moore, H.J.; Worthington, H.V.; Durrington, P.N.; Higgins, J.P.; Capps, N.E.; et al. Risks and benefits of omega 3 fats for mortality, cardiovascular disease, and cancer: Systematic review. BMJ 2006, 332, 752–760.
  133. Marik, P.E.; Varon, J. Omega-3 dietary supplements and the risk of cardiovascular events: A systematic review. Clin. Cardiol. 2009, 32, 365–372.
  134. Rizos, E.C.; Ntzani, E.E.; Bika, E.; Kostapanos, M.S.; Elisaf, M.S. Association between omega-3 fatty acid supplementation and risk of major cardiovascular disease events: A systematic review and meta-analysis. JAMA2012, 308, 1024–1033.
  135. Wang, C.; Harris, W.S.; Chung, M.; Lichtenstein, A.H.; Balk, E.M.; Kupelnick, B.; Jordan, H.S.; Lau, J. n-3 Fatty acids from fish or fish-oil supplements, but not alpha-linolenic acid, benefit cardiovascular disease outcomes in primary- and secondary-prevention studies: A systematic review. Am. J. Clin. Nutr. 2006, 84, 5–17.
  136. Ligresti, A.; Petrosino, S.; Di Marzo, V. From endocannabinoid profiling to “endocannabinoid therapeutics”. Curr. Opin. Chem. Biol. 2009, 13, 321–331.
  137. Taylor, L.A.; Pletschen, L.; Arends, J.; Unger, C.; Massing, U. Marine phospholipids—A promising new dietary approach to tumor-associated weight loss. Support. Care Cancer 2010, 18, 159–170.

Enviromental and Socially Responsible Affiliations

ASOC – Antarctic and Southern Ocean Coalition
ARK – Association of Responsible Krill Harvesting
BAS – British Antarctic Survey
CCAMLR – Commission for the Conservation of Antarctic Marine Living Resources
GOED – Global Organization for EPA & DHA Omega-3s
MRAG – A unique and highly motivated consulting firm
MSC – Marine Stewardship Council
USAP – The United States Antarctic Program
WWF –
Vitamin Angels – Vitamin Angels helps at-risk populations in need.